Pulmonary-renal syndrome in systemic sclerosis: a report of three cases and review of the literature
Authors:
- Taio NaniwaTNTaio Naniwa
- Shogo BannoSBShogo Banno
- Yoshiki SugiuraYSYoshiki Sugiura
- Kaori YokotaKYKaori Yokota
- Tomoyo OosawaTOTomoyo Oosawa
- Shinji MaedaSMShinji Maeda
- Yoshihito HayamiYHYoshihito Hayami
- Nobuyuki TakahashiNTNobuyuki Takahashi
- Ryuzo UedaRURyuzo Ueda
- Yoshifuji MatsumotoYMYoshifuji Matsumoto
- 20 February 2007
- journal article
- case report
- Published by Oxford University Press (OUP) in Modern Rheumatology
- Vol. 17 (1) , 37-44
Abstract
We describe three cases of acute renal failure with diffuse alveolar hemorrhage, which is designated pulmonary-renal syndrome (PRS), in systemic sclerosis (SSc) and review the literature to better define this rare but severe complication of SSc. The clinical course of three SSc patients with acute renal failure and concomitant diffuse alveolar hemorrhage are reported, and the literature published between 1967 and 2005 is reviewed following a PubMed search. Including our cases, a total of 19 SSc patients with acute renal failure and concomitant diffuse alveolar hemorrhage have been reported. Pulmonary-renal syndrome developing in SSc patients can be categorized clinicopathologically into three entities: PRS with thrombotic microangiopathy, PRS with small vessel vasculitides accompanied with SSc, and d-penicillamine-induced Goodpasture-like syndrome. Patients with scleroderma PRS with thrombotic microangiopathy, to which group our all patients belong, often developed diffuse alveolar hemorrhage after receiving high-dose corticosteroid therapy. Pulmonary-renal syndrome is a fatal complication of SSc and results from different pathogenic processes. Prompt differential diagnosis between the subsets is critical, because therapeutic strategy may differ in the use of high-dose corticosteroid and plasma exchange between the subsets of PRS. Clinical courses of the patients with PRS with thrombotic microangiopathy suggest that high-dose corticosteroid therapy is a trigger of diffuse alveolar hemorrhage in patients with diffuse SSc with signs of thrombotic microangiopathy.Keywords
This publication has 20 references indexed in Scilit:
- Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpuraBlood, 2004
- Antibodies to von Willebrand Factor–Cleaving Protease in Acute Thrombotic Thrombocytopenic PurpuraNew England Journal of Medicine, 1998
- von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic SyndromeNew England Journal of Medicine, 1998
- Renal involvement in systemic sclerosisClinics in Dermatology, 1994
- Comparison of Plasma Exchange with Plasma Infusion in the Treatment of Thrombotic Thrombocytopenic PurpuraNew England Journal of Medicine, 1991
- Outcome of Renal Crisis in Systemic Sclerosis: Relation to Availability of Angiotensin Converting Enzyme (ACE) InhibitorsAnnals of Internal Medicine, 1990
- Normotensive renal failure in systemic sclerosisArthritis & Rheumatism, 1989
- Glomerulonephritis with coexistent immune deposits and antibasement membrane activity.Journal of Clinical Pathology, 1984
- Preliminary criteria for the classification of systemic sclerosis (scleroderma)Arthritis & Rheumatism, 1980
- Progressive systemic sclerosis complicated by diffuse pulmonary haemorrhage.Thorax, 1977